COVID-19 and Heart Attack: Long-Term Mortality Risks Revealed

New research presented at the 2026 Society for Cardiovascular Angiography & Interventions (SCAI) conference has revealed a troubling link between COVID-19 and heart attack outcomes. Patients who experience a severe heart attack while infected with COVID-19 face a significantly higher risk of death—even a year after the event—compared to those without the virus. The findings underscore the long-term cardiovascular risks associated with COVID-19, particularly for individuals already vulnerable to heart disease.

COVID-19 and Heart Attack Mortality: A Persistent Threat

The study, which analyzed data from multiple medical centers, found that patients hospitalized for ST-segment elevation myocardial infarction (STEMI)—a severe type of heart attack caused by a complete blockage of a coronary artery—had a 25% higher mortality rate one year later if they also had COVID-19 at the time of the event. This elevated risk persisted regardless of whether the patient had pre-existing heart disease, suggesting that the virus itself may exacerbate cardiovascular damage.

“The combination of COVID-19 and a severe heart attack appears to create a compounding effect on the cardiovascular system,” said a lead researcher involved in the study, as reported by News-Medical. “Even after the acute phase of the infection has passed, these patients remain at higher risk for adverse outcomes.”

Long COVID and Cardiovascular Risks

The findings align with growing evidence that COVID-19 can have lasting effects on heart health, even in individuals who did not experience severe illness during their initial infection. A separate study published in Vaccine Advisor found that adults with Long COVID—persistent symptoms lasting weeks or months after the acute infection—had an increased risk of developing cardiovascular disease. The study noted that Long COVID patients were more likely to experience conditions such as heart failure, arrhythmias and blood clots, which can contribute to long-term complications.

“The cardiovascular system is particularly vulnerable to the lingering effects of COVID-19,” the study authors wrote. “Even mild cases of the virus can lead to inflammation and damage to blood vessels, increasing the risk of future heart problems.”

Higher Mortality Rates Even a Year Later

Research published by Down To Earth further supports the link between COVID-19 and long-term heart attack mortality. The study found that patients who had COVID-19 at the time of their heart attack were more likely to die within a year compared to those who did not have the virus. This elevated risk was observed even in patients who survived the initial hospitalization, suggesting that the virus may cause lasting damage to the heart and blood vessels.

View this post on Instagram about Heart Attack Mortality, Higher Mortality Rates Even

The study also noted that the risk was highest among older adults and those with underlying health conditions, such as diabetes or hypertension. However, even younger patients without pre-existing heart disease were not immune to the increased mortality risk.

Why Does COVID-19 Increase Heart Attack Risks?

While the exact mechanisms behind COVID-19’s impact on the heart are still being studied, researchers have identified several potential factors:

• Inflammation: COVID-19 triggers a strong inflammatory response in the body, which can damage blood vessels and increase the risk of plaque rupture—a leading cause of heart attacks.
• Blood Clots: The virus is known to increase the likelihood of blood clots, which can block coronary arteries and lead to heart attacks or strokes.
• Direct Heart Damage: Some studies suggest that COVID-19 can directly infect heart cells, leading to myocarditis (inflammation of the heart muscle) and other forms of cardiac injury.
• Vascular Aging: Research from the multinational CARTESIAN study, as reported in the World Heart Federation background materials, found that COVID-19 accelerates vascular aging, increasing arterial stiffness and raising long-term cardiovascular risk.

These findings highlight the importance of monitoring heart health in COVID-19 survivors, particularly those who experienced severe illness or have pre-existing cardiovascular conditions.

Blood Type and Cardiovascular Risk

Adding another layer of complexity, research led by the Cleveland Clinic and the University of Southern California found that blood type may influence cardiovascular risk after COVID-19. The study, published in Arteriosclerosis, Thrombosis, and Vascular Biology, revealed that individuals with blood types A, B, or AB were twice as likely to experience a major cardiac event—such as a heart attack, stroke, or death—after COVID-19 compared to those with blood type O.

“This suggests that genetic factors may play a role in how COVID-19 affects the cardiovascular system,” said Dr. Stanley Hazen, co-senior author of the study and chair of Cardiovascular and Metabolic Sciences at Cleveland Clinic’s Lerner Research Institute. “While we don’t yet understand the exact mechanisms, this finding could help identify individuals who may need closer monitoring after infection.”

What This Means for Patients and Providers

The accumulating evidence underscores the need for heightened cardiovascular monitoring in COVID-19 survivors, particularly those who experienced severe illness or have pre-existing risk factors. Healthcare providers may need to adopt more aggressive preventive strategies, such as:

• Regular cardiovascular screenings for COVID-19 survivors, including blood pressure checks, cholesterol tests, and imaging studies to assess heart and blood vessel health.
• Early intervention for patients with Long COVID, including medications to reduce inflammation or prevent blood clots.
• Lifestyle modifications, such as diet and exercise, to mitigate long-term cardiovascular risks.
• Increased awareness among patients about the potential long-term effects of COVID-19 on heart health, even if they did not experience severe symptoms during their initial infection.

For patients, the findings serve as a reminder that COVID-19 is not just a respiratory illness but a systemic condition with potential long-term consequences. Those who have had COVID-19—especially those who were hospitalized or experienced severe symptoms—should be vigilant about their heart health and seek medical attention if they experience symptoms such as chest pain, shortness of breath, or fatigue.

Unanswered Questions and Future Research

While the research provides critical insights into the link between COVID-19 and heart attack mortality, many questions remain unanswered. For example:

• How long does the increased risk last? Most studies have focused on the first year after infection, but it is unclear whether the elevated risk persists beyond that timeframe.
• What role do vaccines play? Some studies suggest that COVID-19 vaccination may reduce the risk of severe illness and long-term complications, but more research is needed to determine whether vaccines also lower cardiovascular risks.
• Are certain variants more dangerous? The studies cited in this article primarily reflect data from the early waves of the pandemic. It is unclear whether newer variants of the virus pose the same level of cardiovascular risk.

Ongoing research, including long-term follow-up studies, will be essential to fully understand the relationship between COVID-19 and heart health. In the meantime, the findings serve as a stark reminder that the pandemic’s impact on public health extends far beyond the acute phase of the illness.

Key Takeaways

• Patients who experience a severe heart attack while infected with COVID-19 face a 25% higher risk of death within one year compared to those without the virus.
• Long COVID is associated with an increased risk of cardiovascular disease, including heart failure, arrhythmias, and blood clots.
• COVID-19 may cause lasting damage to the heart and blood vessels, increasing the risk of future heart attacks and strokes.
• Individuals with blood types A, B, or AB are twice as likely to experience a major cardiac event after COVID-19 compared to those with blood type O.
• Healthcare providers should consider more aggressive cardiovascular monitoring and preventive strategies for COVID-19 survivors, particularly those with pre-existing risk factors.

As the world continues to grapple with the long-term effects of COVID-19, these findings highlight the importance of ongoing research and vigilance in protecting heart health. For now, patients and providers alike must remain aware of the potential risks and take proactive steps to mitigate them.